NCT06692452 2026-04-01Tazemetostat Plus CHOP in 1L T-cell LymphomaDana-Farber Cancer InstitutePhase 2 Withdrawn
NCT04795869 2023-10-10Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell LymphomaNorthwestern UniversityPhase 2 Withdrawn
NCT00621036 2018-11-26Vaccine Therapy and GM-CSF in Treating Patients With CNS LymphomaUniversity of Texas Southwestern Medical CenterPhase 2 Withdrawn
NCT01652014 2016-07-14Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesRutgers, The State University of New JerseyPhase 2 Withdrawn